• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
ISPE 2025: Real-world data survival patterns in glioblastoma patients

ISPE 2025: Real-world data survival patterns in glioblastoma patients

by Truveta Research | Aug 22, 2025 | Research, Research Insights

Authors: Mantas Dmukauskas, PhD ⊕Truveta, Inc, Bellevue, WA, Sarah Blach, MS ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Amy Wu ⊕Truveta, Inc, Bellevue, WA The survival rate for patients with glioblastoma (GBM) differs significantly by...
ISPE 2025: Active surveillance of mosquito-borne diseases in the United States

ISPE 2025: Active surveillance of mosquito-borne diseases in the United States

by Truveta Research | Aug 22, 2025 | Research, Research Insights

Authors: Katie Kendrick, MPH ⊕Truveta, Inc, Bellevue, WA, Amy Sullivan, MS ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Agnes Pastwa ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA Truveta Data is well-suited to...
ISPE 2025: Active surveillance of foodborne diseases in the United States

ISPE 2025: Active surveillance of foodborne diseases in the United States

by Truveta Research | Aug 22, 2025 | Research, Research Insights

Authors: Katie Kendrick, MPH ⊕Truveta, Inc, Bellevue, WA, Amy Sullivan, MS ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Agnes Pastwa ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA Truveta Data is well-suited to...
ISPE 2025: A real-world risk stratification approach to pulmonary embolism using Truveta Data

ISPE 2025: A real-world risk stratification approach to pulmonary embolism using Truveta Data

by Truveta Research | Aug 22, 2025 | Research, Research Insights

Authors: Amy Austin, MS ⊕Truveta, Inc, Bellevue, WA, Emily Webber, PhD ⊕Truveta, Inc, Bellevue, WA, Sarah Blach, MS ⊕Truveta, Inc, Bellevue, WA, Jared Kern ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA, Sally Omidvar, MSPH, MS ⊕Truveta, Inc,...
Infection risk and adoption trends in hemodialysis catheters: New real-world evidence

Infection risk and adoption trends in hemodialysis catheters: New real-world evidence

by Truveta staff | Jul 31, 2025 | Research

Can catheter design impact patient safety? That’s the question of a new peer-reviewed study from Medical Components, Inc. (Medcomp), based on a retrospective analysis of 3,546 catheter insertions captured in Truveta Data. Used to deliver life-sustaining dialysis...
« Older Entries

Share this


Recent posts

  • Real-world analysis links Dexcom CGM use to reduced progression of chronic kidney disease
  • Truveta experts: Gestational diabetes screening in real-world practice
  • Non-small cell lung cancer: Biomarkers, treatments, and outcomes in real-world data

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.